Literature DB >> 11692059

Impact of irritable bowel syndrome on personal relationships and working practices.

D B Silk1.   

Abstract

OBJECTIVE: To determine the impact of irritable bowel syndrome on personal relationships and working practices. PATIENTS AND METHODS: A 60-item questionnaire about personal relationships, working practices and treatment was sent to 3090 subscribers of the IBS Bulletin, a quarterly educational publication. A total of 1855 completed questionnaires were returned. Analysis was restricted to 1597 questionnaires (86.1%), returned by respondents in whom the diagnosis of irritable bowel syndrome had been made by a general practitioner or hospital specialist.
RESULTS: Of these respondents, 57% were aged 55 or over and the male to female ratio was 1:3.4. On average, respondents had suffered from irritable bowel syndrome for 16.6 years, with 57% reporting their symptoms daily, 25% weekly and 14% monthly. Of the married or cohabiting respondents, 19% stated that their partner experienced difficulties in having a personal relationship with them and 45% stated that irritable bowel syndrome interfered with their sex life. Irritable bowel syndrome had caused 12% of respondents to give up work altogether, while 47% of employed respondents reported having lost time off work, although only 35% of these respondents gave irritable bowel syndrome as the reason. In contrast employers, when informed of the diagnosis of irritable bowel syndrome, accepted these symptoms as a valid reason for absence in 61% of instances. Over half of those employed (53%) suffered embarrassment using toilets at work and 32% stated that irritable bowel syndrome had stopped them from applying for promotion or a new job. At the time of completing the questionnaire, 80% of respondents were actually taking some form of treatment. Smooth-muscle relaxants and fibre supplements remained the commonest treatments prescribed.
CONCLUSION: Irritable bowel syndrome impacts significantly on personal relationships and working practices. Items that stimulate responsiveness in the areas of personal relationships and working practices should be included in the construction of disease-specific questionnaires used to assess the impact of new treatments for irritable bowel syndrome on health-related quality of life.

Entities:  

Mesh:

Year:  2001        PMID: 11692059     DOI: 10.1097/00042737-200111000-00011

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

1.  Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.

Authors:  Prashant Singh; Kyle Staller; Kenneth Barshop; Elaine Dai; Jennifer Newman; Sonia Yoon; Shahar Castel; Braden Kuo
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 2.  The role of gender and biological sex in irritable bowel syndrome.

Authors:  Christine L Frissora; Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2005-08

Review 3.  The global impact of IBS: time to think about IBS-specific models of care?

Authors:  Maura Corsetti; Peter Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2017-07-31       Impact factor: 4.409

4.  Intestinal microecology and quality of life in irritable bowel syndrome patients.

Authors:  Jian-Min Si; Ying-Cong Yu; Yu-Jing Fan; Shu-Jie Chen
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

Review 5.  Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview.

Authors:  Theodor Bokic; Martin Storr; Rudolf Schicho
Journal:  Pharmacology       Date:  2015-07-01       Impact factor: 2.547

6.  The importance of relationships in patients with irritable bowel syndrome: a review.

Authors:  Mary-Joan Gerson; Charles D Gerson
Journal:  Gastroenterol Res Pract       Date:  2011-12-01       Impact factor: 2.260

7.  Prevalence, Behaviours and Burden of Irritable Bowel Syndrome in Medical Students and Junior Doctors.

Authors:  Pisani Anthea; Farrugia Tiziana; Panzavecchia Francesca; Ellul Pierre
Journal:  Ulster Med J       Date:  2021-02-26

8.  Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449].

Authors:  C P Dancey; E A Attree; K F Brown
Journal:  Nutr J       Date:  2006-06-08       Impact factor: 3.271

9.  Non-pharmacological treatments for irritable bowel syndrome: study protocol of an umbrella review of systematic review and meta-analyses.

Authors:  Song Jin; Yi-Fan Li; Di Qin; Dan-Qing Luo; Hong Guo; Xiu-Hua Gao; Ling Yue; Hui Zheng
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

10.  Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome.

Authors:  Åsa Frändemark; Hans Törnblom; Magnus Simrén; Sofie Jakobsson
Journal:  BMC Gastroenterol       Date:  2022-02-19       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.